Basal-like breast cancer: a critical review.

By E. Rakha, J. Reis-Filho, Ian O. Ellis. Journal of Clinical Oncology, 2008

953 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/fa82a34788dbe3aa6562fd774cb626cc2f9a92a2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Oncology

Citations in the corpus

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology (2014, background): “In both tissues, these basal cells represent a multipotent “stem/progenitor cell” population (35, 36) and their similar functional roles may explain their similar molecular profiles.”
Triple negative tumours: a critical review (2007, background): “From a scientific perspective, microarraybased expression profiling analysis remains the ‘gold standard’ for the identification of basal-like breast cancers.(57) However, for the foreseeable future, this technology is unlikely to be introduced in the diagnostic armamentarium for breast cancer patien”
An overview of triple-negative breast cancer (2016, background): “associated breast cancer also have TNBC subtype [17, 21].”
Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. (2012, neutral): “The BLC entity partially overlaps with the larger triple-negative breast carcinoma (TNBC) disease (1).”
High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients. (2012, background): “Food and Drug Administration–approved targeted therapy is available to improve patient outcomes [2].”
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. (2010, background): “In particular, most displayed features characteristic of the majority of human basal-like breast cancers (Rakha et al., 2008).”